Animal Science Products, Inc. v. Hebei Welcome Pharmaceutical Co.

This U.S. Supreme Court case arose from a class-action antitrust lawsuit filed by Animal Science Products, Inc. and other vitamin C purchasers against Hebei Welcome Pharmaceutical Co. and other Chinese manufacturers. The plaintiffs alleged a conspiracy to fix prices and limit exports of vitamin C to the United States. The defendants invoked the foreign sovereign compulsion defense, arguing that Chinese law required them to coordinate prices through a government-mandated export cartel. The Ministry of Commerce of China filed an amicus brief supporting this interpretation of Chinese law. The district court and Second Circuit deferred substantially to the Chinese government’s statement. The Supreme Court unanimously reversed, holding that federal courts are not bound to treat a foreign government’s description of its own laws as conclusive, but must carefully consider it under Rule 44.1 alongside other relevant evidence.

The U.S. Supreme Court unanimously vacated the Second Circuit's judgment and remanded the case. It ruled that while a foreign government's submission regarding its own laws is entitled to respectful consideration, it is not dispositive. Courts must independently determine foreign law under Federal Rule of Civil Procedure 44.1, weighing all relevant evidence.

Whether a U.S. federal court is required to treat a foreign government's characterization of its own domestic law as binding and conclusive, or may conduct an independent examination of that foreign law when a defendant raises a defense of foreign sovereign compulsion in an antitrust case.

The decision significantly limited the conclusive weight previously afforded to foreign sovereign statements in U.S. litigation, particularly affecting international trade and antitrust defenses. It signaled to multinational companies that claiming state compulsion would face rigorous judicial scrutiny, impacting the calculus of foreign exporters dealing with conflicting U.S. and home-country regulations. The ruling also added a layer of complexity to U.S.-China commercial relations by rejecting absolute deference to the Chinese government's legal interpretations.